Effect of pioglitazone on metabolic features in endotoxemia model in obese diabeticdb/dbmice
- 17 August 2016
- journal article
- Published by Wiley in Journal of Diabetes
- Vol. 9 (6) , 613-621
Abstract
Background: Infectious diseases are more frequent in diabetic patients, leading to increased morbidity and mortality. Endotoxemia affects glucose metabolism and lipolytic capacity. The aims of the present study were to determine whether endotoxemia exacerbates metabolic features (adipose inflammation, adipogenesis, and insulin resistance [IR]) in an animal model of diabetes (i.e.db/dbmice) after acute infection and the effects of pioglitazone.Methods: Femaledb/dbmice treated with pioglitazone (3 and 30 mg/kg, p.o.) for 14 days were challenged with lipopolysaccharide (LPS; 200 μg/kg), followed by an oral glucose tolerance test (OGTT). Quantitative real‐time polymerase chain reaction (PCR) was used to evaluate the expression of genes in white adipose tissue (WAT) involved in: (i) adipogenesis (lipoprotein lipase [Lpl], fatty acid binding protein‐4 [Ap2] and adiponectin [Adipoq]); (ii) insulin signaling (peroxisome proliferator‐activated receptor gamma [Pparg], suppressor of cytokine signaling 3 [Socs3], solute carrier family 2 [facilitated glucose transporter], member 4 [Slc2a4]); and (iii) inflammation (tumor necrosis factor [Tnf], interleukin‐6 [Il6], monocyte chemoattractant protein‐1 [Ccl2], cyclo‐oxygenase‐2 [prostaglandin‐endoperoxide synthase 2;Ptgs2]).Results: Experimental endotoxemia downregulated mRNA expression ofPparg,Slc2a4,Adipoq,Lpl, andAp2, which coincided with upregulation ofIl6,Tnf,Ccl2,Ptgs2, andSocs3expression. Pioglitazone dose‐dependently decreasedTnf,Il6,Ccl2,Ptgs2, andSocs3expression in WAT, in association with upregulation ofLpl,Ap2,Slc2a4, andAdipoqexpression, indicating improvement in endotoxin‐induced IR.Conclusions: The findings suggest that LPS challenge exacerbates IR indb/dbmice by altering the expression of genes in WAT involved in adipogenesis and inflammation, which is effectively controlled by pioglitazone treatment.Keywords
This publication has 44 references indexed in Scilit:
- A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin ResistanceScience, 2008
- Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?British Journal of Pharmacology, 2007
- Inflammation and metabolic disordersNature, 2006
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJournal of Clinical Investigation, 2006
- Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 DiabetesObesity, 2006
- CCR2 modulates inflammatory and metabolic effects of high-fat feedingJournal of Clinical Investigation, 2006
- The Effect of Helicobacter pylori on Insulin ResistanceDigestive Diseases and Sciences, 2005
- Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2004
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993